Observer variation in immunohistochemical analysis of protein expression, time for a change?
- 23 May 2006
- journal article
- Published by Wiley in Histopathology
- Vol. 48 (7) , 787-794
- https://doi.org/10.1111/j.1365-2559.2006.02412.x
Abstract
Immunohistochemical analysis of protein expression is central to most clinical translational studies and defines patient treatment or selection criteria for novel drugs. Interobserver variation is rarely analysed despite recognition that this is a key area of potential inaccuracy. Therefore our aim was to examine observer variation and suggest the revision of current standards. We analysed inter- and intra-observer variation, by interclass correlation coefficient (ICCC) and kappa statistics, in 8661 samples. Intra-observer assessment of nuclear, cytoplasmic and membrane staining for seven proteins in 1323 samples resulted in an ICCC of 0.94 and a kappa-value of 0.787. Interobserver reproducibility, assessed on 28 proteins by seven observer pairs in 8661 carcinomas, gave an ICCC of 0.90 and a kappa-value of 0.70. No significant effect of either antibody or cellular compartmentalization was observed. We have demonstrated that ICCC is a consistent method to assess observer variation when a continuous scoring system is used, compared with kappa statistics, which depends on a categorical system. Given the importance of accurate assessment of protein expression in diagnostic and experimental medicine, we suggest raising thresholds for observer variation: ICCC of 0.7 should be regarded as the minimum acceptable standard, ICCC of 0.8 as good and ICCC of > or = 0.9 as excellent.Keywords
This publication has 35 references indexed in Scilit:
- Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer?Clinical Cancer Research, 2005
- Type I receptor tyrosine kinases are associated with hormone escape in prostate cancerThe Journal of Pathology, 2005
- Her2/neu Expression Predicts the Response to Antiaromatase Neoadjuvant Therapy in Primary Breast CancerClinical Cancer Research, 2004
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003
- Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerBritish Journal of Cancer, 2003
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003
- Amplification of the androgen receptor gene in bone metastases from hormone‐refractory prostate cancerThe Journal of Pathology, 2002
- Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related componentsEuropean Journal Of Cancer, 1998
- Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical methodEuropean Journal of Cancer and Clinical Oncology, 1987